8020 CANNABIS

publicPublic Group

This group is dedicated to Cannabis information and discussions. Corporations on the 8020 platform which do not offer investors a "private investor group" may post corporate related content in this investor group.

people169 Members       (0)

Corporate Profile
Group Admins:
  • Thumb b7c819c2f8949d2a4df7a13fade3f5a1 bpfull
Join Group


8020 CANNABIS

publicPublicGroup

This group is dedicated to Cannabis information and discussions. Corporations on the 8020 platform which do not offe......

people169 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

4 days ago

8020 Admin posted an update Experion Partners with Leading Hemp Supplier to Secure Access to Hemp-based CBD in 8020 CANNABIS

VANCOUVER, BC / ACCESSWIRE / September 17, 2019 / Experion Holdings Ltd. (TSXV: EXP) (OTCQB: EXPFF) (FRANKFURT: MB31), formerly Viridium Pacific Group Ltd today announced that Experion Holdings Ltd. (“Experion” or “the Company’’), entered into a non-binding term sheet (the ‘’Term Sheet’’) with True North Cannabis Corp. (‘’True North’’), a Canadian hemp harvest service provider with a core focus on facilitating the supply of bulk, extract-ready, pre-concentrated, tested high potency hemp-based CBD. The Term Sheet contemplates guaranteed access to top quality CBD Biomass that is explicitly processed and manufactured ready for extracting high quality CBD oils for value-added products. Experion will also make an equity investment in True North.


Mr. Jay Garnett, Chief Executive Officer, commented, “We are excited to partner with an emerging leader in hemp aggregation in the CBD extraction space. Partnering with True North provides Experion with access to low-cost, high-quality, extract-ready hemp material for processing. We believe that Experion will be able to leverage hemp-derived CBD products as a critical entrant into the emerging US and International markets as hemp-derived CBD products become more widely accepted.


The Term Sheet contemplates that Experion will receive a right of first refusal on True North’s premium hemp-based CBD Biomass. To start, Experion will have access to 6,000 kilograms of high-potency hemp-based CBD Biomass for the 2019 harvest season and at least 6,000 kilograms for every year going forward. The terms of a supply agreement, if executed by Experion and True North, may differ from those outlined in this press release.


Mr. Jay Garnett further commented, “As the cannabis industry continues to evolve, consumers will look to different forms of cannabis, a trend we are already witnessing, and we believe CBD from Hemp will form the basis of an expanding category. Our partnership with True North will enable Experion to aggregate up to 6,000 kilograms of high-potency hemp-based CBD Biomass which is a highly economical extraction model for us starting in 2019. Furthermore, it allows us to adjust our capacity needs each year without being beholden to a specific number of kilograms. Finally, we also believe that in order to remain competitive, it is important to have strategic partners specializing in outdoor grow. Our arrangement with True North provides excellent flexibility at a low-cost, and the ability to produce desired products for our customers and revenue for our shareholders.”


About True North Cannabis


True North Cannabis is a Canadian hemp harvest service provider with a core focus on facilitating the supply of bulk, extract-ready, hemp-based CBD.


With a grower focused service model, True North supports industrial hemp growers across Canada to effectively commercialize the cannabinoid content from their harvest. By providing access to state-of-the-art infrastructure and hemp chaff expertise, True North manages the unique challenges in bridging broad acre agriculture and the Cannabis industry.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP" on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”


For further information, please visit the Company’s website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases or contact Investor Relations directly


Judy-Ann Pottinger, Investor Relations Manager
Phone: 604- 617-5290
Email: judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.

!
Thumb 8020 monitor 200200 2

8020 Admin

6 days ago

8020 Admin posted an update Experion Engages Mackie Research Capital for Market Making Services in 8020 CANNABIS

VANCOUVER, BC / ACCESSWIRE / September 16, 2019 / Experion Holdings Ltd. (TSXV: EXP) (OTCQB: EXPFF) (FRANKFURT: MB31), formerly Viridium Pacific Group Ltd today announced that Experion Holdings. (“Experion or “the Company’’ is pleased to announce that, subject to regulatory approval, the Company has signed an agreement with Mackie Research Capital Corporation (“MRCC”) to provide market-making services to the Company in compliance with the policies and guidelines of the TSX Venture Exchange and other applicable legislation.


The Services will be undertaken by MRCC, a registered broker, in compliance with the applicable polices of the Exchange and other applicable laws and with its corporate business address 199 Bay Street, Commerce Court West, Suite 4500, P.O. Box 368 Toronto, Ontario M5L 1G2. Beginning September 1, 2019, MRCC will trade shares of Experion on the TSXV with the objective of maintaining a reasonable market and improving the liquidity of Experion’s common shares. Under the terms of the agreement, MRCC will receive $4,500 cash per month payable quarterly in advance. The agreement will continue in effect unless terminated by either party by providing at least 30 days written or verbal notice. There are no performance factors contained in the agreement, and MRCC will not receive shares or options as compensation. MRCC and the Company are unrelated and unaffiliated entities, but Mackie and/or its clients may have an interest, directly or indirectly, in the securities of the Company.


Experion canceled its market-making agreement with Integral Wealth Securities Limited who was engaged August 1, 2018.


About Mackie Research Capital Corporation


Mackie is one of Canada's largest independent full-service investment firms, and proudly traces its roots back to 1921. Mackie is privately owned by many of its 300 employees. As a fully integrated national investment dealer, Mackie offers a full complement of capital markets and wealth management services to private clients, institutions and growth companies.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP" on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”


For further information, please visit the Company’s website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases


Contact Investor Relations
Judy-Ann Pottinger
Phone: 604- 617-5290
Email: judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/559776/Experion-Engages-Mackie-Research-Capital-for-Market-Making-Services

!
Thumb 8020 media relations

Media Relations posted an update in 8020 CANNABIS

9 days ago

After the incredible Global Growth in Cannabis mixer, presented by the CSE, MNP, and Aird & Berlis, CSE CEO Richard Carleton and Grace Pedota, the CSE’s Listings, Marketing & Events Coordinator, took advantage of the great weather to shoot an interview outside of the iconic Steam Whistle Brewing. Thanks to everyone who joined us!


Thumb 7af302a9 a644 411d 98d9 d234bad006f9 large

Thumb 8020 media relations

Media Relations posted an update in 8020 CANNABIS

10 days ago

Where the short and long-term opportunities are in cannabis
Emily Paxhia, co-founder and managing director at Poseidon Asset Management, joins BNN Bloomberg to discuss current opportunities in the cannabis industry. She sees the nurturing of a craft industry and thinks that the medicinal side will be a better opportunity further out.

https://www.bnnbloomberg.ca/commodities/video/where-the-short-and-long-term-opportunities-are-in-cannabis~1775867

Thumb 8020 monitor 200200 2

8020 Admin

12 days ago

8020 Admin posted an update Experion Holdings Ltd. Signs LOI with the Société Québécoise du Cannabis (SQDC) to Supply Cannabis Products for Distribution and Sale in the Province in 8020 CANNABIS

VANCOUVER, BC and MONTREAL, QC / ACCESSWIRE / September 10, 2019 / Experion Holdings Ltd. (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd today announced that its wholly-owned subsidiary Experion Biotechnologies Inc. (“Experion or “the Company’’), a Health Canada licensed cultivator and processor of Cannabis has signed a Letter of Intent ("LOI") with the Société québécoise du cannabis (“SQDC”) Québec’s sole legal retailer of recreational cannabis, to supply Adult-Use cannabis products to the SQDC for distribution and sale in the Province of Québec.


Mr. Jay Garnett, Chief Executive Officer, commented “We are pleased to work with the SQDC and deliver products that will meet the demand of its customers. This agreement further solidifies Experion’s position in Canada's legal adult use cannabis marketplace expanding our distribution beyond British Columbia and Saskatchewan”


Under the terms of the LOI, Experion through its wholly owned Kanabé Goods Co. (‘’ Kanabé”), an adult-use health & wellness brand, will supply products in the form of THC and CBD oil capsules. Shipments to Québec are scheduled to start in December and continue throughout 2020.


Ms. Krystal Laferriere, Experion’s Cannabis Wellness Expert and Co-Founder of Kanabé Goods Co. who had created the product line to soothe side-effects and other ailments suffered as a result of her Crohn’s Disease, commented, "Part of Experion’s growth strategy is focused on establishing a strong national footprint and building our brand presence. It is a great accomplishment to have Québec as Kanabé’s entry point into the domestic market. Our capsules will serve those looking for a micro-dose, option made from our full spectrum oil. Kanabé will also roll out more products such as oral sprays. We are proud to have this opportunity to partner with Québec and the SDQC to help ensure Canadians have access to a reliable supply of adult-use cannabis products”


About Kanabe Goods Co


Kanabé Goods Co. www.kanabe.ca creates therapeutic health and wellness products containing cannabis and has over 50 formulations in its portfolio including topical salves, lotions, oils as well as edible oils and capsules. Kanabé products were developed to target and soothe various aliments by combining cannabinoids, terpenes and aromatherapy with a focus on discretion and ease of use by developing products that are already found in consumers everyday life. Kanabé is an adult-use, over-the-counter health & wellness brand ingraining into daily actions and rituals for comfort and solutions to acute problems ranging from sore muscles, to sleep and skin issues.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP" on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”


For further information, please visit the Company’s website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases or contact Investor Relations, Judy-Ann Pottinger, Phone: 604- 617-5290 Email: judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/559044/Experion-Holdings-Ltd-Signs-LOI-with-the-Socit-Qubcoise-du-Cannabis-SQDC-to-Supply-Cannabis-Products-for-Distribution-and-Sale-in-the-Province

!
Thumb jim photo

Jim Durward posted an update in 8020 CANNABIS

12 days ago

Regarding the vape controversy. There are lots of carts with varying hole numbers, varying hole location in the cart, and various hole sizes - specifically meant to deal with varying viscosities. Ideally, manufacturers are supposed to match the hole number/location/size to the viscosity of their product. Lots of big holes to deal with thick oils and a smaller number of smaller holes to deal with thin oils. I have tried many different carts to see which hole numbers/location/sizes deal best with the various viscosities created by different cut ratios. At the end of the day, it's my position is that if you're craft grower looking to establish a small batch premium brand that can command higher prices, it's best to use zero diluent of any kind. Use raw, full-spectrum oil with a ceramic cart with big, floor holes and you can project a very favourable marketing image - especially today when the diluent bru-ha-ha is all over the news. With the proper cart (such as used by the refillable LINX Hermes 3 (no affiliation)) that I am now using, raw CO2-based oil can go directly into the cart and provides a great tasting, very potent diluent-free vape. Other extraction methods may not be able to validly make this claim. Yes, it costs more to fill a cart but you should be able to sell uncut carts at a premium - and that's what craft is all about - quality. And that's the market Medxtractor CO2-based extractors address. The photo shows raw CO2 oil on the left and the same oil in the Hermes. I don't have to concern myself about diluents.


Thumb linx hermes 3 and raw co2 oil

Thumb jim photo

Jim Durward commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

Thumb jim photo

Jim Durward commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

Thumb jim photo

Jim Durward commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

Thumb 8020 media relations

Media Relations posted an update in 8020 CANNABIS

12 days ago

The CSE will be the proud host of the Cannabis Global Capital & Commercialization Conference, taking place on September 16th in Tel Aviv, Israel.

Attending guests will enjoy an exclusive, expert-driven conference designed to support cannabis companies in the globalization of their capital markets and business development strategies. Discussion will be focused on the global regulatory environment, ways to access capital in North America and Europe, and strategies for the effective commercialization of cannabis company brands.

Register and find out more about the conference here.

https://thecse.com/en/about/event/cannabis-global-capital-commercialization

Thumb no photo

roberge commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

Thumb jim photo

Jim Durward commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

8020 CANNABIS

publicPublic Group

This group is dedicated to Cannabis information and discussions. Corporations on the 8020 platform which do not offer investors a "private investor group" may post corporate related content in this investor group.

people169 Members       (0)

Corporate Profile
Group Admins:
  • Thumb b7c819c2f8949d2a4df7a13fade3f5a1 bpfull
Join Group


8020 CANNABIS

publicPublicGroup

This group is dedicated to Cannabis information and discussions. Corporations on the 8020 platform which do not offe......

people169 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

4 days ago

8020 Admin posted an update Experion Partners with Leading Hemp Supplier to Secure Access to Hemp-based CBD in 8020 CANNABIS

VANCOUVER, BC / ACCESSWIRE / September 17, 2019 / Experion Holdings Ltd. (TSXV: EXP) (OTCQB: EXPFF) (FRANKFURT: MB31), formerly Viridium Pacific Group Ltd today announced that Experion Holdings Ltd. (“Experion” or “the Company’’), entered into a non-binding term sheet (the ‘’Term Sheet’’) with True North Cannabis Corp. (‘’True North’’), a Canadian hemp harvest service provider with a core focus on facilitating the supply of bulk, extract-ready, pre-concentrated, tested high potency hemp-based CBD. The Term Sheet contemplates guaranteed access to top quality CBD Biomass that is explicitly processed and manufactured ready for extracting high quality CBD oils for value-added products. Experion will also make an equity investment in True North.


Mr. Jay Garnett, Chief Executive Officer, commented, “We are excited to partner with an emerging leader in hemp aggregation in the CBD extraction space. Partnering with True North provides Experion with access to low-cost, high-quality, extract-ready hemp material for processing. We believe that Experion will be able to leverage hemp-derived CBD products as a critical entrant into the emerging US and International markets as hemp-derived CBD products become more widely accepted.


The Term Sheet contemplates that Experion will receive a right of first refusal on True North’s premium hemp-based CBD Biomass. To start, Experion will have access to 6,000 kilograms of high-potency hemp-based CBD Biomass for the 2019 harvest season and at least 6,000 kilograms for every year going forward. The terms of a supply agreement, if executed by Experion and True North, may differ from those outlined in this press release.


Mr. Jay Garnett further commented, “As the cannabis industry continues to evolve, consumers will look to different forms of cannabis, a trend we are already witnessing, and we believe CBD from Hemp will form the basis of an expanding category. Our partnership with True North will enable Experion to aggregate up to 6,000 kilograms of high-potency hemp-based CBD Biomass which is a highly economical extraction model for us starting in 2019. Furthermore, it allows us to adjust our capacity needs each year without being beholden to a specific number of kilograms. Finally, we also believe that in order to remain competitive, it is important to have strategic partners specializing in outdoor grow. Our arrangement with True North provides excellent flexibility at a low-cost, and the ability to produce desired products for our customers and revenue for our shareholders.”


About True North Cannabis


True North Cannabis is a Canadian hemp harvest service provider with a core focus on facilitating the supply of bulk, extract-ready, hemp-based CBD.


With a grower focused service model, True North supports industrial hemp growers across Canada to effectively commercialize the cannabinoid content from their harvest. By providing access to state-of-the-art infrastructure and hemp chaff expertise, True North manages the unique challenges in bridging broad acre agriculture and the Cannabis industry.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP" on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”


For further information, please visit the Company’s website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases or contact Investor Relations directly


Judy-Ann Pottinger, Investor Relations Manager
Phone: 604- 617-5290
Email: judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.

!
Thumb 8020 monitor 200200 2

8020 Admin

6 days ago

8020 Admin posted an update Experion Engages Mackie Research Capital for Market Making Services in 8020 CANNABIS

VANCOUVER, BC / ACCESSWIRE / September 16, 2019 / Experion Holdings Ltd. (TSXV: EXP) (OTCQB: EXPFF) (FRANKFURT: MB31), formerly Viridium Pacific Group Ltd today announced that Experion Holdings. (“Experion or “the Company’’ is pleased to announce that, subject to regulatory approval, the Company has signed an agreement with Mackie Research Capital Corporation (“MRCC”) to provide market-making services to the Company in compliance with the policies and guidelines of the TSX Venture Exchange and other applicable legislation.


The Services will be undertaken by MRCC, a registered broker, in compliance with the applicable polices of the Exchange and other applicable laws and with its corporate business address 199 Bay Street, Commerce Court West, Suite 4500, P.O. Box 368 Toronto, Ontario M5L 1G2. Beginning September 1, 2019, MRCC will trade shares of Experion on the TSXV with the objective of maintaining a reasonable market and improving the liquidity of Experion’s common shares. Under the terms of the agreement, MRCC will receive $4,500 cash per month payable quarterly in advance. The agreement will continue in effect unless terminated by either party by providing at least 30 days written or verbal notice. There are no performance factors contained in the agreement, and MRCC will not receive shares or options as compensation. MRCC and the Company are unrelated and unaffiliated entities, but Mackie and/or its clients may have an interest, directly or indirectly, in the securities of the Company.


Experion canceled its market-making agreement with Integral Wealth Securities Limited who was engaged August 1, 2018.


About Mackie Research Capital Corporation


Mackie is one of Canada's largest independent full-service investment firms, and proudly traces its roots back to 1921. Mackie is privately owned by many of its 300 employees. As a fully integrated national investment dealer, Mackie offers a full complement of capital markets and wealth management services to private clients, institutions and growth companies.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP" on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”


For further information, please visit the Company’s website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases


Contact Investor Relations
Judy-Ann Pottinger
Phone: 604- 617-5290
Email: judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/559776/Experion-Engages-Mackie-Research-Capital-for-Market-Making-Services

!
Thumb 8020 media relations

Media Relations posted an update in 8020 CANNABIS

9 days ago

After the incredible Global Growth in Cannabis mixer, presented by the CSE, MNP, and Aird & Berlis, CSE CEO Richard Carleton and Grace Pedota, the CSE’s Listings, Marketing & Events Coordinator, took advantage of the great weather to shoot an interview outside of the iconic Steam Whistle Brewing. Thanks to everyone who joined us!


Thumb 7af302a9 a644 411d 98d9 d234bad006f9 large

Thumb 8020 media relations

Media Relations posted an update in 8020 CANNABIS

10 days ago

Where the short and long-term opportunities are in cannabis
Emily Paxhia, co-founder and managing director at Poseidon Asset Management, joins BNN Bloomberg to discuss current opportunities in the cannabis industry. She sees the nurturing of a craft industry and thinks that the medicinal side will be a better opportunity further out.

https://www.bnnbloomberg.ca/commodities/video/where-the-short-and-long-term-opportunities-are-in-cannabis~1775867

Thumb 8020 monitor 200200 2

8020 Admin

12 days ago

8020 Admin posted an update Experion Holdings Ltd. Signs LOI with the Société Québécoise du Cannabis (SQDC) to Supply Cannabis Products for Distribution and Sale in the Province in 8020 CANNABIS

VANCOUVER, BC and MONTREAL, QC / ACCESSWIRE / September 10, 2019 / Experion Holdings Ltd. (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd today announced that its wholly-owned subsidiary Experion Biotechnologies Inc. (“Experion or “the Company’’), a Health Canada licensed cultivator and processor of Cannabis has signed a Letter of Intent ("LOI") with the Société québécoise du cannabis (“SQDC”) Québec’s sole legal retailer of recreational cannabis, to supply Adult-Use cannabis products to the SQDC for distribution and sale in the Province of Québec.


Mr. Jay Garnett, Chief Executive Officer, commented “We are pleased to work with the SQDC and deliver products that will meet the demand of its customers. This agreement further solidifies Experion’s position in Canada's legal adult use cannabis marketplace expanding our distribution beyond British Columbia and Saskatchewan”


Under the terms of the LOI, Experion through its wholly owned Kanabé Goods Co. (‘’ Kanabé”), an adult-use health & wellness brand, will supply products in the form of THC and CBD oil capsules. Shipments to Québec are scheduled to start in December and continue throughout 2020.


Ms. Krystal Laferriere, Experion’s Cannabis Wellness Expert and Co-Founder of Kanabé Goods Co. who had created the product line to soothe side-effects and other ailments suffered as a result of her Crohn’s Disease, commented, "Part of Experion’s growth strategy is focused on establishing a strong national footprint and building our brand presence. It is a great accomplishment to have Québec as Kanabé’s entry point into the domestic market. Our capsules will serve those looking for a micro-dose, option made from our full spectrum oil. Kanabé will also roll out more products such as oral sprays. We are proud to have this opportunity to partner with Québec and the SDQC to help ensure Canadians have access to a reliable supply of adult-use cannabis products”


About Kanabe Goods Co


Kanabé Goods Co. www.kanabe.ca creates therapeutic health and wellness products containing cannabis and has over 50 formulations in its portfolio including topical salves, lotions, oils as well as edible oils and capsules. Kanabé products were developed to target and soothe various aliments by combining cannabinoids, terpenes and aromatherapy with a focus on discretion and ease of use by developing products that are already found in consumers everyday life. Kanabé is an adult-use, over-the-counter health & wellness brand ingraining into daily actions and rituals for comfort and solutions to acute problems ranging from sore muscles, to sleep and skin issues.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP" on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”


For further information, please visit the Company’s website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases or contact Investor Relations, Judy-Ann Pottinger, Phone: 604- 617-5290 Email: judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/559044/Experion-Holdings-Ltd-Signs-LOI-with-the-Socit-Qubcoise-du-Cannabis-SQDC-to-Supply-Cannabis-Products-for-Distribution-and-Sale-in-the-Province

!
Thumb jim photo

Jim Durward posted an update in 8020 CANNABIS

12 days ago

Regarding the vape controversy. There are lots of carts with varying hole numbers, varying hole location in the cart, and various hole sizes - specifically meant to deal with varying viscosities. Ideally, manufacturers are supposed to match the hole number/location/size to the viscosity of their product. Lots of big holes to deal with thick oils and a smaller number of smaller holes to deal with thin oils. I have tried many different carts to see which hole numbers/location/sizes deal best with the various viscosities created by different cut ratios. At the end of the day, it's my position is that if you're craft grower looking to establish a small batch premium brand that can command higher prices, it's best to use zero diluent of any kind. Use raw, full-spectrum oil with a ceramic cart with big, floor holes and you can project a very favourable marketing image - especially today when the diluent bru-ha-ha is all over the news. With the proper cart (such as used by the refillable LINX Hermes 3 (no affiliation)) that I am now using, raw CO2-based oil can go directly into the cart and provides a great tasting, very potent diluent-free vape. Other extraction methods may not be able to validly make this claim. Yes, it costs more to fill a cart but you should be able to sell uncut carts at a premium - and that's what craft is all about - quality. And that's the market Medxtractor CO2-based extractors address. The photo shows raw CO2 oil on the left and the same oil in the Hermes. I don't have to concern myself about diluents.


Thumb linx hermes 3 and raw co2 oil

Thumb jim photo

Jim Durward commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

Thumb jim photo

Jim Durward commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

Thumb jim photo

Jim Durward commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

Thumb 8020 media relations

Media Relations posted an update in 8020 CANNABIS

12 days ago

The CSE will be the proud host of the Cannabis Global Capital & Commercialization Conference, taking place on September 16th in Tel Aviv, Israel.

Attending guests will enjoy an exclusive, expert-driven conference designed to support cannabis companies in the globalization of their capital markets and business development strategies. Discussion will be focused on the global regulatory environment, ways to access capital in North America and Europe, and strategies for the effective commercialization of cannabis company brands.

Register and find out more about the conference here.

https://thecse.com/en/about/event/cannabis-global-capital-commercialization

Thumb no photo

roberge commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.

Thumb jim photo

Jim Durward commented on roberge  update in 8020 CANNABIS

12 days ago

If you are interested in California cannabis concentrate business, we will be presenting in Edmonton on Tuesday Sept. 10th at the Craft Beer Market 230pm, and at the Metropolitan in Calgary on Thursday Sept 12th at 230pm. Please RSVP to me to reserve your seat.